Hammerich, Linda http://orcid.org/0000-0003-0557-3927
Tacke, Frank http://orcid.org/0000-0001-6206-0226
Article History
Accepted: 7 June 2023
First Online: 3 July 2023
Competing interests
: F.T.’s laboratory has received research funding from Allergan, Bristol-Myers Squibb, Gilead and Inventiva (funding to the institution). F.T. has received honoraria for consulting or lectures from Astra Zeneca, Gilead, AbbVie, BMS, Boehringer, Madrigal, Intercept, Falk, Ionis, Inventiva, Merz, Pfizer, Alnylam, NGM, CSL Behring, Novo Nordisk and Novartis. L.H. declares no competing interests.